Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Randomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich Ataxia.

Lynch DR, Hauser L, McCormick A, Wells M, Dong YN, McCormack S, Schadt K, Perlman S, Subramony SH, Mathews KD, Brocht A, Ball J, Perdok R, Grahn A, Vescio T, Sherman JW, Farmer JM.

Ann Clin Transl Neurol. 2019 Feb 27;6(3):546-553. doi: 10.1002/acn3.731. eCollection 2019 Mar.

2.

Impact of Mobility Device Use on Quality of Life in Children With Friedreich Ataxia.

Ejaz R, Chen S, Isaacs CJ, Carnevale A, Wilson J, George K, Delatycki MB, Perlman SL, Mathews KD, Wilmot GR, Hoyle JC, Subramony SH, Zesiewicz T, Farmer JM, Lynch DR, Yoon G.

J Child Neurol. 2018 May;33(6):397-404. doi: 10.1177/0883073818764941. Epub 2018 Apr 2.

PMID:
29607705
3.

Treating refractory depression in Parkinson's disease: a meta-analysis of transcranial magnetic stimulation.

Lesenskyj AM, Samples MP, Farmer JM, Maxwell CR.

Transl Neurodegener. 2018 Mar 22;7:8. doi: 10.1186/s40035-018-0113-0. eCollection 2018. Review.

4.

Comorbid Medical Conditions in Friedreich Ataxia: Association With Inflammatory Bowel Disease and Growth Hormone Deficiency.

Shinnick JE, Schadt K, Strawser C, Wilcox N, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Yiu EM, Delatycki MB, Brocht AF, Farmer JM, Lynch DR.

J Child Neurol. 2016 Aug;31(9):1161-5. doi: 10.1177/0883073816643408. Epub 2016 Apr 12.

PMID:
27071470
5.

Frataxin levels in peripheral tissue in Friedreich ataxia.

Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, Christie C, Perlman SL, Wilmot GR, Gomez CM, Mathews KD, Yoon G, Zesiewicz T, Hoyle C, Subramony SH, Brocht AF, Farmer JM, Wilson RB, Deutsch EC, Lynch DR.

Ann Clin Transl Neurol. 2015 Aug;2(8):831-42. doi: 10.1002/acn3.225. Epub 2015 Jul 1.

6.

Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants.

Regner SR, Wilcox NS, Friedman LS, Seyer LA, Schadt KA, Brigatti KW, Perlman S, Delatycki M, Wilmot GR, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Ravina B, Brocht A, Farmer JM, Lynch DR.

J Child Neurol. 2012 Sep;27(9):1152-8. doi: 10.1177/0883073812448462. Epub 2012 Jun 29.

7.

Novel diagnostic paradigms for Friedreich ataxia.

Brigatti KW, Deutsch EC, Lynch DR, Farmer JM.

J Child Neurol. 2012 Sep;27(9):1146-51. doi: 10.1177/0883073812448440. Epub 2012 Jun 29. Review.

8.

Exploration of transitional life events in individuals with Friedreich ataxia: implications for genetic counseling.

White VB, Leib JR, Farmer JM, Biesecker BB.

Behav Brain Funct. 2010 Oct 27;6:65. doi: 10.1186/1744-9081-6-65.

9.

A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia.

Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, Lynch DR.

Mol Genet Metab. 2010 Oct-Nov;101(2-3):238-45. doi: 10.1016/j.ymgme.2010.07.001. Epub 2010 Jul 8.

10.

Pregnancy with Friedreich ataxia: a retrospective review of medical risks and psychosocial implications.

Friedman LS, Paulsen EK, Schadt KA, Brigatti KW, Driscoll DA, Farmer JM, Lynch DR.

Am J Obstet Gynecol. 2010 Sep;203(3):224.e1-5. doi: 10.1016/j.ajog.2010.03.046. Epub 2010 May 15.

PMID:
20478553
11.

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR.

Mov Disord. 2010 Mar 15;25(4):426-32. doi: 10.1002/mds.22912.

12.

Clinical measures of dysarthria in Friedreich Ataxia.

Singh A, Epstein E, Myers LM, Farmer JM, Lynch DR.

Mov Disord. 2010 Jan 15;25(1):108-11. doi: 10.1002/mds.22776.

PMID:
20014117
13.

Urinary isoprostanes in Friedreich ataxia: lack of correlation with disease features.

Myers LM, Lynch DR, Farmer JM, Friedman LS, Lawson JA, Wilson RB.

Mov Disord. 2008 Oct 15;23(13):1920-2. doi: 10.1002/mds.22038.

PMID:
18671287
14.

Health related quality of life measures in Friedreich Ataxia.

Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR.

J Neurol Sci. 2008 Sep 15;272(1-2):123-8. doi: 10.1016/j.jns.2008.05.009. Epub 2008 Jun 20.

PMID:
18571673
15.

Novel, complex interruptions of the GAA repeat in small, expanded alleles of two affected siblings with late-onset Friedreich ataxia.

Stolle CA, Frackelton EC, McCallum J, Farmer JM, Tsou A, Wilson RB, Lynch DR.

Mov Disord. 2008 Jul 15;23(9):1303-6. doi: 10.1002/mds.22012.

PMID:
18464277
16.

Mortality in Friedreich's Ataxia.

Lynch DR, Farmer JM, Wilson RB.

Tex Heart Inst J. 2007;34(4):502-3; author reply 503-4. No abstract available.

17.

Antioxidant use in Friedreich ataxia.

Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR.

J Neurol Sci. 2008 Apr 15;267(1-2):174-6. Epub 2007 Nov 7.

18.

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.

Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK; DLB/PDD Working Group.

Neurology. 2007 Mar 13;68(11):812-9. Review.

PMID:
17353469
19.

Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.

Van Deerlin VM, Forman MS, Farmer JM, Grossman M, Joyce S, Crowe A, Trojanowski JQ, Lee VM, Chatterjee A.

Acta Neuropathol. 2007 Apr;113(4):471-9. Epub 2006 Oct 28.

PMID:
17072625
21.

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ.

Neurology. 2006 Jun 13;66(11):1711-6.

PMID:
16769945
22.

Comparison of family histories in FTLD subtypes and related tauopathies.

Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, Lomen-Hoerth C, Wilhelmsen KC, Lee VM, Grossman M, Miller BL.

Neurology. 2005 Dec 13;65(11):1817-9.

PMID:
16344531
23.

Performance measures in Friedreich ataxia: potential utility as clinical outcome tools.

Lynch DR, Farmer JM, Wilson RL, Balcer LJ.

Mov Disord. 2005 Jul;20(7):777-82.

PMID:
15747359
24.

Frontotemporal dementia: genetics and genetic counseling dilemmas.

Goldman JS, Farmer JM, Van Deerlin VM, Wilhelmsen KC, Miller BL, Grossman M.

Neurologist. 2004 Sep;10(5):227-34. Review.

PMID:
15335440
25.

Olfactory dysfunction in degenerative ataxias.

Connelly T, Farmer JM, Lynch DR, Doty RL.

J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1435-7.

26.

Familial frontotemporal dementia: from gene discovery to clinical molecular diagnostics.

Van Deerlin VM, Gill LH, Farmer JM, Trojanowski JQ, Lee VM.

Clin Chem. 2003 Oct;49(10):1717-25. Review.

27.

Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia.

Lynch DR, Farmer JM, Rochestie D, Balcer LJ.

J Neuroophthalmol. 2002 Dec;22(4):270-4.

PMID:
12464730
28.

Neurogenetics. Introduction.

Lynch DR, Farmer JM.

Neurol Clin. 2002 Aug;20(3):xi-xii. No abstract available.

PMID:
12432822
29.

The decision to salvage or amputate a severely injured limb.

Hiatt MD, Farmer JM, Teasdall RD.

J South Orthop Assoc. 2000 Spring;9(1):72-8; discussion 78.

PMID:
12132814
30.

Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.

Lynch DR, Farmer JM, Balcer LJ, Wilson RB.

Arch Neurol. 2002 May;59(5):743-7. Review.

PMID:
12020255
31.

Near infrared muscle spectroscopy in patients with Friedreich's ataxia.

Lynch DR, Lech G, Farmer JM, Balcer LJ, Bank W, Chance B, Wilson RB.

Muscle Nerve. 2002 May;25(5):664-73.

PMID:
11994959
32.

Chondral and osteochondral injuries. Diagnosis and management.

Farmer JM, Martin DF, Boles CA, Curl WW.

Clin Sports Med. 2001 Apr;20(2):299-320. Review.

PMID:
11398360
33.

A cyanide-bridged bimetallic complex,

Combs RA, Farmer JM, Kautz JA.

Acta Crystallogr C. 2000 Dec;56 (Pt 12):1420-2.

PMID:
11118972
34.

Preparation of new anti-tubulin ligands through a dual-mode, addition-elimination reaction to a bromo-substituted alpha, beta-unsaturated sulfoxide.

Chen Z, Mocharla VP, Farmer JM, Pettit GR, Hamel E, Pinney KG.

J Org Chem. 2000 Dec 15;65(25):8811-5. No abstract available.

PMID:
11112609
35.

Increased serum transferrin receptor concentrations in Friedreich ataxia.

Wilson RB, Lynch DR, Farmer JM, Brooks DG, Fischbeck KH.

Ann Neurol. 2000 May;47(5):659-61.

PMID:
10805340
36.

Frataxin point mutations in two patients with Friedreich's ataxia and unusual clinical features.

McCormack ML, Guttmann RP, Schumann M, Farmer JM, Stolle CA, Campuzano V, Koenig M, Lynch DR.

J Neurol Neurosurg Psychiatry. 2000 May;68(5):661-4.

37.

Quality of life assessment by patients with inflammatory bowel disease.

Farmer RG, Easley KA, Farmer JM.

Cleve Clin J Med. 1992 Jan-Feb;59(1):35-42.

PMID:
1551212
38.

Complications following postpartum sterilization by bilateral tubal ligation.

Cook CL, Farmer JM.

J Ky Med Assoc. 1984 Apr;82(4):171-4.

PMID:
6538896
39.

Effects of beta-adrenergic amines on frog gastric mucosa.

Farmer JM, Carrasquer G, Holloman TL, Schwartz M.

Proc Soc Exp Biol Med. 1978 Feb;157(2):256-61. No abstract available.

PMID:
23553
40.

Effects of norepinephrine and phentolamine on frog gastric mucosa in chlorida solutions.

Rose J, Schwartz M, Farmer JM, Carrasquer G.

Proc Soc Exp Biol Med. 1977 May;155(1):59-63. No abstract available.

PMID:
300881

Supplemental Content

Loading ...
Support Center